Allianz Asset Management
BRLI

Allianz Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Allianz Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,774
Closed -$309K – 2603
2015
Q1 		$309K Hold
8,774
– – ﹤0.01% 2110
2014
Q4 		$282K Hold
8,774
– – ﹤0.01% 2126
2014
Q3 		$246K Sell
8,774
-3,800
-30% -$116K ﹤0.01% 2107
2014
Q2 		$380K Sell
12,574
-72
-0.6% -$1.99K ﹤0.01% 1651
2014
Q1 		$350K Sell
12,646
-18,564
-59% -$486K ﹤0.01% 1663
2013
Q4 		$797K Buy
31,210
+19,610
+169% +$604K ﹤0.01% 1444
2013
Q3 		$347K Buy
+11,600
New +$323K ﹤0.01% 1586

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Allianz Asset Management's BRLI Position: Q2 2015 in Review

Allianz Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 8,774 shares — an estimated $309K sold.

Allianz Asset Management first reported a position in BRLI in Q3 2013 and held it in 7 quarters. The position peaked at $797K in Q4 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Allianz Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Allianz Asset Management sold 8,774 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $309K.
  • Allianz Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 7 quarters.
  • Allianz Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $797K in Q4 2013.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.